Proposed Data Collections Submitted for Public Comment and Recommendations, 76458-76459 [E5-7863]

Download as PDF 76458 Federal Register / Vol. 70, No. 247 / Tuesday, December 27, 2005 / Notices Number of responses per respondent Number of Respondents Respondents Average burden per response (in hrs.) Total burden (in hours) High-Level Management Staff ......................................................................... Mid-level Staff .................................................................................................. Local-level Staff ............................................................................................... 16 32 32 1 1 1 1.5 1.5 1.5 11 21 21 Total .......................................................................................................... 80 ........................ ........................ 53 Dated: December 19, 2005. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E5–7862 Filed 12–23–05; 8:45 am] use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. BILLING CODE 4163–18–P Proposed Project Aerosol Generation by Cough— NEW—The National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–06–06AP] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–4766 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the Background and Brief Description The Federal Occupational Safety and Health Act of 1970, section 501, enables NIOSH to carry out research relevant to the health and safety of workers. NIOSH is conducting a two year study of airborne clouds of particles or droplets called ‘‘aerosols’’. Some diseases like influenza and Severe Acute Respiratory Syndrome (SARS) can be spread when people produce infectious aerosols by coughing or sneezing. Aerosol transmission of infectious diseases is especially important to health-care workers and emergency responders, who face a much greater risk of exposure to these hazards than does the general public. Cough-generated aerosols are of particular concern because coughing is one of the most common symptoms of respiratory infections. However, substantial gaps exist in our understanding about the generation of aerosols during coughing. This lack of information hampers the ability of health scientists to model and predict the generation of infectious aerosols by coughing and to understand whether or not cough-generated aerosols are likely to be an important means of transmission of particular diseases. The purpose of this study is to gain a better understanding of the production of aerosols by coughing. The results of this research will give scientists and health professionals’ greater insight into Number of respondents bjneal on PROD1PC70 with NOTICES Respondents Part 1 participants ............................................................................................ Part 2 participants ............................................................................................ VerDate Aug<31>2005 14:54 Dec 23, 2005 Jkt 208001 PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 the airborne transmission of disease and allow them to better assess the potential effectiveness of preventive measures. The first part of this study will measure the quantity and size distribution of aerosol produced during human coughs. To accomplish this, volunteers will cough into a spirometer, which is a commonly used piston-like medical device that measures the volume of air exhaled by a patient. After the volunteer coughs into the spirometer, the air in the spirometer will be drawn into a commercial aerosol measurement device. These experiments will also provide information on how much cough aerosols vary over time for individuals and how much aerosol generation varies between individuals. The second part of this study will determine how effectively surgical masks and N95 respirators block coughgenerated aerosols. N95 respirators are dust masks that are certified to filter out at least 95% of airborne material during normal breathing. N95 respirators are known to be more effective than surgical masks at filtering out airborne particles during inhalation, but it is not known whether masks or respirators are more effective at blocking cough-generated aerosols. For this work, masks and respirators will be placed in a special holder with a disposable mouthpiece, and human subjects will cough into the mouthpiece and through the mask. The aerosol produced by each subject will be analyzed before and after flowing through the mask. These experiments will determine how effective each mask or respirator is at preventing the release of cough-generated aerosols. Volunteers from part 1 may also participate in part 2 if they wish. There will be no costs to study participants other than their time. Estimates of Annualized Burden Number of responses per respondent 20 120 E:\FR\FM\27DEN1.SGM 5 1 27DEN1 Average burden per response (in hours) 1.5 1.5 Total burden (in hours) 150 180 76459 Federal Register / Vol. 70, No. 247 / Tuesday, December 27, 2005 / Notices Number of respondents Respondents Total .......................................................................................................... Dated: December 19, 2005. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E5–7863 Filed 12–23–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention bjneal on PROD1PC70 with NOTICES Request for Nominations of Candidates To Serve on the Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Department of Health and Human Services The National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (NCEH/ ATSDR) is soliciting nominations for possible membership on the Board of Scientific Counselors. This Board provides advice and guidance to the Secretary, Department of Health and Human Services (HHS); the Director, Centers for Disease Control and Prevention (CDC); and the Director, NCEH/ATSDR, regarding program goals, objectives, strategies, and priorities in fulfillment of the agencies’ mission to protect and promote people’s health. The Board provides advice and guidance to help NCEH/ATSDR work more efficiently and effectively with its various constituents and to fulfill its mission in protecting America’s health. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishments of the Board’s objectives. Nominees will be selected from experts having experience in preventing human diseases and disabilities caused by environmental conditions. Experts in the disciplines of toxicology, epidemiology, environmental or occupational medicine, behavioral science, risk assessment, exposure assessment, and experts in public health and other related disciplines will be considered. Consideration is given to representation from diverse geographic areas, gender, ethnic and minority groups, and the disabled. Members may be invited to VerDate Aug<31>2005 14:54 Dec 23, 2005 Jkt 208001 Number of responses per respondent Average burden per response (in hours) ........................ ........................ ........................ serve up to four-year terms. Nominees must be U.S. citizens. The following information must be submitted for each candidate: Name, affiliation, address, telephone number, and current curriculum vitae. E-mail addresses are requested if available. Nominations should be sent, in writing, and postmarked by January 9, 2006 to: Sandra Malcom, Committee Management Specialist, NCEH/ATSDR, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., (MS–E28), Atlanta, Georgia 30333. Telephone and facsimile submissions cannot be accepted. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the National Center for Environmental Health/Agency for Toxic Substances and Disease Registry. Dated: December 19, 2005. Alvin Hall, Director, Management Analysis and Services Office Centers for Disease Control and Prevention (CDC). [FR Doc. E5–7859 Filed 12–23–05; 8:45 am] Total burden (in hours) 330 being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Chapman Valve Co. Location: Indian Orchard, Massachusetts. Job Titles and/or Job Duties: Various. Period of Employment: From 1948 through 1949 and from 1991–1995 (DOE Remediation). FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health, 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513–533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. Dated: December 20, 2005. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. E5–7809 Filed 12–23–05; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Decision To Evaluate a Petition To Designate a Class of Employees at Chapman Valve Co., Indian Orchard, Massachusetts, To Be Included in the Special Exposure Cohort Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: SUMMARY: The Department of Health and Human Services (HHS) gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees at the Chapman Valve Co., in Indian Orchard, Massachusetts, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class PO 00000 Frm 00018 Fmt 4703 Sfmt 4703 Designation of a Class of Employees for Addition to the Special Exposure Cohort Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: SUMMARY: The Department of Health and Human Services (HHS) gives notice of a decision to designate a class of employees at the Linde Ceramics Plant, in Tonawanda, New York as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On December 8, 2005, the Secretary of HHS designated the following class of employees as an addition to the SEC: Atomic weapons employees who worked at the Linde Ceramic Plant from October 1, 1942, through October 31, 1947, and who were employed for a number of work days aggregating at least 250 work days, either solely under this employment or in E:\FR\FM\27DEN1.SGM 27DEN1

Agencies

[Federal Register Volume 70, Number 247 (Tuesday, December 27, 2005)]
[Notices]
[Pages 76458-76459]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E5-7863]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-06-06AP]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-4766 
and send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an email 
to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Aerosol Generation by Cough--NEW--The National Institute for 
Occupational Safety and Health (NIOSH), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The Federal Occupational Safety and Health Act of 1970, section 
501, enables NIOSH to carry out research relevant to the health and 
safety of workers. NIOSH is conducting a two year study of airborne 
clouds of particles or droplets called ``aerosols''. Some diseases like 
influenza and Severe Acute Respiratory Syndrome (SARS) can be spread 
when people produce infectious aerosols by coughing or sneezing. 
Aerosol transmission of infectious diseases is especially important to 
health-care workers and emergency responders, who face a much greater 
risk of exposure to these hazards than does the general public. Cough-
generated aerosols are of particular concern because coughing is one of 
the most common symptoms of respiratory infections. However, 
substantial gaps exist in our understanding about the generation of 
aerosols during coughing. This lack of information hampers the ability 
of health scientists to model and predict the generation of infectious 
aerosols by coughing and to understand whether or not cough-generated 
aerosols are likely to be an important means of transmission of 
particular diseases.
    The purpose of this study is to gain a better understanding of the 
production of aerosols by coughing. The results of this research will 
give scientists and health professionals' greater insight into the 
airborne transmission of disease and allow them to better assess the 
potential effectiveness of preventive measures.
    The first part of this study will measure the quantity and size 
distribution of aerosol produced during human coughs. To accomplish 
this, volunteers will cough into a spirometer, which is a commonly used 
piston-like medical device that measures the volume of air exhaled by a 
patient. After the volunteer coughs into the spirometer, the air in the 
spirometer will be drawn into a commercial aerosol measurement device. 
These experiments will also provide information on how much cough 
aerosols vary over time for individuals and how much aerosol generation 
varies between individuals.
    The second part of this study will determine how effectively 
surgical masks and N95 respirators block cough-generated aerosols. N95 
respirators are dust masks that are certified to filter out at least 
95% of airborne material during normal breathing. N95 respirators are 
known to be more effective than surgical masks at filtering out 
airborne particles during inhalation, but it is not known whether masks 
or respirators are more effective at blocking cough-generated aerosols. 
For this work, masks and respirators will be placed in a special holder 
with a disposable mouthpiece, and human subjects will cough into the 
mouthpiece and through the mask. The aerosol produced by each subject 
will be analyzed before and after flowing through the mask. These 
experiments will determine how effective each mask or respirator is at 
preventing the release of cough-generated aerosols.
    Volunteers from part 1 may also participate in part 2 if they wish. 
There will be no costs to study participants other than their time.

Estimates of Annualized Burden

----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
                   Respondents                      respondents    responses per   response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Part 1 participants.............................              20               5             1.5             150
Part 2 participants.............................             120               1             1.5             180
                                                 -----------------

[[Page 76459]]

 
    Total.......................................  ..............  ..............  ..............             330
----------------------------------------------------------------------------------------------------------------


    Dated: December 19, 2005.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E5-7863 Filed 12-23-05; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.